Cradle
Generative AI protein engineering platform
Cradle provides a generative AI platform for protein engineering that enables scientists to design improved proteins in a fraction of the time required by traditional methods. The platform is used across therapeutics, diagnostics, food, chemicals, and agriculture by clients including Novo Nordisk and Johnson & Johnson. With 31 molecules in development on its platform, Cradle has established itself as a leading AI tool for industrial protein optimization.
Generative Chemistry, Foundation Models, Platform
Funding
$100M+
Total raised
$73M
Led by IVP
IVP · Index Ventures · Kindred Capital
Technology
Generative AI platform for protein engineering. The system designs and optimizes protein sequences for improved function, stability, and manufacturability across multiple application areas. Cradle's in-house wet lab generates proprietary data to train and validate its models.
Leadership
Stef van Grieken
CEO & Co-Founder
Partnerships
Similar companies
Boltz PBC
Open-source biomolecular AI for drug discovery
platform · 2026Latent Labs
Making biology programmable with generative AI
platform · 2025Basecamp Research
World's largest biodiversity-powered protein database for AI
platform · 2019Absci Corporation
AI-powered de novo antibody design and creation
preclinical · 2011Get updates on Cradle
We'll notify you when we publish updates about Cradle.